Pier V. Piazza

Affiliations: 
Université de Bordeaux, Talence, Nouvelle-Aquitaine, France 
Google:
"Pier Piazza"
Mean distance: 14.28 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Haney M, Vallée M, Fabre S, et al. (2023) Signaling-specific inhibition of the CB receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. Nature Medicine
Kearney-Ramos T, Herrmann ES, Belluomo I, et al. (2022) The Relationship Between Circulating Endogenous Cannabinoids and the Effects of Smoked Cannabis. Cannabis and Cannabinoid Research
Di Franco N, Drutel G, Roullot-Lacarrière V, et al. (2022) Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model. Molecular and Cellular Neurosciences. 103705
Ducourneau EG, Guette C, Perrot D, et al. (2020) Brexpiprazole blocks post-traumatic stress disorder-like memory while promoting normal fear memory. Molecular Psychiatry
Jimenez-Blasco D, Busquets-Garcia A, Hebert-Chatelain E, et al. (2020) Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature. 583: 603-608
Deroche-Gamonet V, Revest JM, Fiancette JF, et al. (2018) Depleting adult dentate gyrus neurogenesis increases cocaine-seeking behavior. Molecular Psychiatry
Devroye C, Cathala A, Piazza PV, et al. (2017) The central serotonin2B receptor as a new pharmacological target for the treatment of dopamine-related neuropsychiatric disorders: Rationale and current status of research. Pharmacology & Therapeutics
Metna-Laurent M, Mondésir M, Grel A, et al. (2017) Cannabinoid-Induced Tetrad in Mice. Current Protocols in Neuroscience. 80: 9.59.1-9.59.10
Caraci F, Enna SJ, et al. (2017) A New Nomenclature for Classifying Psychotropic Drugs. British Journal of Clinical Pharmacology
Devroye C, Haddjeri N, Cathala A, et al. (2017) Opposite controls of mesocortical and mesoaccumbal dopamine pathways by serotonin2B receptor blockade: Involvement of medial prefrontal cortex serotonin1A receptors. Neuropharmacology
See more...